Neurology News

A web-based system for the diagnosis and treatment of recurrent benign paroxysmal positional vertigo was shown to be effective, researchers reported in JAMA Neurology.

PB006, the first biosimilar for natalizumab, showed comparable safety, efficacy and immunogenicity to the reference monoclonal antibody therapy in patients with relapsing-remitting MS, researchers wrote in JAMA Neurology.

Head injury was associated with decreased long-term survival time in a community-based cohort with more than 30 years of follow-up, researchers wrote in JAMA Neurology.

Risk scores and machine learning algorithms were less accurate at predicting stroke for Black adults than for white adults, researchers reported in JAMA.

Neurogene Inc. announced the FDA has granted clearance to its investigational new drug application for NGN-401, an adeno-associated virus gene therapy candidate for treating Rett syndrome in female pediatric patients.

Sleep quality in patients with type 1 diabetes may be improved with disease management as well as interventions supporting resilience and reducing negative emotions, researchers reported in BMC Psychiatry.

Individuals with mental disorders who attempted suicide were reported to have impaired or abnormal social decision-making, evidenced by neuro-electrophysiological activity, according to a study published in BMC Psychiatry.

Stemedica Cell Technologies announced the launch of a phase 2b/3 clinical trial to assess the safety, efficacy and tolerability of a single IV injection of allogenic mesenchymal stem cells in patients with chronic ischemic stroke.

Ralph L. Sacco, MD, MS, professor and chair of the department of neurology at the University of Miami Miller School of Medicine, died on Jan. 17 from glioblastoma, according to a statement from the university.

An early return to school and other life activities following a concussion were associated with a lower symptom burden and faster recovery among children and adolescents, researchers reported in JAMA Network Open.